Bedside platelet function testing requires further research before routine clinical implementation can be recommended.
Answers are grounded in this paper and cite their sources.
Platelet aggregometry should not guide therapy; leaves open its clinical utility pending prospective validation.
The ability to test platelet reactivity in clinical practice could help in making informed decisions on both initiation and titration of anti-platelet drug therapies. However, many barriers still remain to the effective implementation of such techniques. Many tests used in the research literature are not yet available for practical, clinical use. Platelet aggregometry, while informative and currently available for bedside use, needs additional research before routine clinical use can be recommended. This review will highlight and update contemporary issues of bedside platelet testing for the clinician and comment on future areas of clinical research.
No takes yet. Share an insight, caveat, or question.
Cherala et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: